aldevron.com
Aldevron and IDT have announced the successful manufacture of the world’s first personalized CRISPR gene editing drug product to treat an infant with urea cycle disorder (UCD).
Social
N/A
App
Category
science_and_education/biology
Monetization
Unknown
Domain Information
Site Overview
Site Engagments
52.75%
Bounce Rate
Pages Per Visit
1
Total Visits
14.3K
Time on Site
00:00:30
Traffic Sources
Social
6.99%
Paid
1.02%
Mail
0.07%
Referrals
5.71%
Search
37.71%
Direct
48.50%
Traffic Top 5 Country
72.86%
11.15%
5.55%
3.90%
2.49%
Google Ads Overview
Google SEO Overview
Posts
| Title | Author | View | Comments | Last Update |
|---|